Status:
COMPLETED
Intracoronary Injection of Autologous Bone Marrow Cells in Patients With Chronic Heart Failure: Five Years Follow up
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Chronic Ischemic Symptomatic Heart Failure
Eligibility:
All Genders
18-88 years
Phase:
PHASE2
Brief Summary
The study aim is to evaluate the long term outcome of intra-coronary autologous bone marrow (BM) transplantation in patients with severe ischemic cardiomyopathy without the option for revascularizatio...
Detailed Description
Several studies have demonstrated the short term safety, feasibility and efficacy of cell transplantation in patients with advanced heart failure. There are no data about the long term outcome.
Eligibility Criteria
Inclusion
- Patients with evidence of hibernation and/or ischemia in at least 2 different myocardial segments underwent coronary angiography
Exclusion
- Idiopathic or non-ischemic cardiomyopathy
- Other etiology for heart failure, history of past or current disease involving the bone marrow
- Patients on dialysis
- Positive serologic test for HIV, hepatitis B or C or any neoplastic or terminal disease
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00933621
Start Date
April 1 2003
End Date
December 1 2003
Last Update
July 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofeh
Ẕerifin, Israel, 70300